# Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine

> **NCT00323375** · PHASE1 · COMPLETED · sponsor: **Tulane University Health Sciences Center** · enrollment: 122 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** AQ-13
- **DRUG:** Chloroquine (CQ) Treatment

## Key facts

- **NCT ID:** NCT00323375
- **Lead sponsor:** Tulane University Health Sciences Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08-01
- **Primary completion:** 2005-06-30
- **Final completion:** 2005-08-31
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2020-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00323375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00323375, "Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00323375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*